Vanguard Group Inc Emergent Bio Solutions Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,584,213 shares of EBS stock, worth $31.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,584,213
Previous 3,214,003
11.52%
Holding current value
$31.9 Million
Previous $15.6 Million
46.4%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding EBS
# of Institutions
187Shares Held
39.4MCall Options Held
277KPut Options Held
151K-
Black Rock Inc. New York, NY3.84MShares$34.2 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$32.2 Million2.74% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$20.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$16.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.74MShares$15.5 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $444M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...